DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)

Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens  of various pathogens as genetically engineered vaccines  both  preventive and ther...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2017
Materias:
Acceso en línea:https://doaj.org/article/873ea27afa2e4dde939b3d79061df97c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!